secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kaya Holdings, Inc. (KAYS)
CIK:        0001530746
Form:       8-K
Filed at:   2023-10-23T23:59:59+00:00
Accession:  0001903596-23-000804
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

KAYS closes additional $600K non-dilutive bridge financing for Oregon psilocybin center
--------------------------------------------------------------------------------

- Total bridge financing since June 2023 is $600K: $100K short-term due Mar 15, 2023, $500K repayable from 10% of quarterly revenues, balance due Jun 30, 2025.
- Funds are non-dilutive, not convertible into stock, and carry no commissions or fees.
- Company expects to submit Oregon Health Authority license application in 30 days and open The Sacred Mushroom facility within 90 days of approval.
- The 11,000 sq ft facility will include a microdosing café, private treatment rooms, group areas, and activity zones aiming for lower pricing than competitors.
- KAYS believes it is the only U.S. public company pursuing an OHA psilocybin treatment center license.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1530746/000190359623000804/0001903596-23-000804-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1530746/000190359623000804/kays_8k.htm
  HTML page:      https://secwatch.observer/filing/0001903596-23-000804

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer